Tumores Ginecológicos

Revisão | Câncer endometrial.

13 Dez, 2021 | 11:21h

Endometrial cancer – Nature Reviews Disease Primers (gratuito por tempo limitado – se o acesso a este link for pago, tente este)

Infográfico: Endometrial cancer (gratuito por tempo limitado – se o acesso a este link for pago, tente este)

Estudo randomizado | Cirurgia citorredutora para recidiva de câncer de ovário.

2 Dez, 2021 | 11:19h

Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer – New England Journal of Medicine

Recomendações para mulheres com câncer ginecológico que receberam tratamento não padrão durante a pandemia de COVID-19.

19 Nov, 2021 | 13:01h

British Gynaecological Cancer Society recommendations for women with gynecological cancer who received non-standard care during the COVID-19 pandemic – International Journal of Gynecological Cancer

Programa nacional de vacinação contra HPV na Inglaterra foi associado com uma redução estimada de 87% nas taxas de câncer do colo do útero naquelas que receberam a vacina entre 12-13 anos de idade.

4 Nov, 2021 | 11:59h

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study – The Lancet

Conteúdos relacionados:

Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer

CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination

Meta-Analysis: Population-level Impact of HPV Vaccination Programs

Comentário no Twitter

NEW—Cervical cancer rates 87% lower in women offered vaccination against human papillomavirus (#HPV) between ages 12-13 than in previous generations, English study confirms.

First direct evidence of cervical cancer prevention using bivalent vaccine: https://t.co/HdQbGIKxZp pic.twitter.com/PMFermHGOv

— The Lancet (@TheLancet) November 3, 2021

Estudo randomizado | Pembrolizumabe para câncer de colo do útero metastático, recorrente ou persistente.

27 Set, 2021 | 13:14h

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer – New England Journal of Medicine

Comentário: KEYNOTE-826: Pembrolizumab Plus Chemotherapy in Advanced Cervical Cancer – The ASCO Post

Diretrizes para a abordagem perioperatória de pacientes com câncer ovariano avançado que serão submetidas a cirurgia citorredutora.

26 Ago, 2021 | 12:12h

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking surgery – International Journal of Gynecological Cancer

Editorial: Standardizing ovarian cancer surgery and peri-operative care: a European Society of Gynecological Oncology (ESGO) consensus statement

Estudo de coorte | Uso de contraceptivo oral e risco de câncer ovariano para portadoras de mutações nos genes BRCA1/2.

20 Ago, 2021 | 12:02h

Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study – American Journal of Obstetrics and Gynecology

Comentário no Twitter

For #BRCA1 mutation carriers, longer duration of oral contraceptive use (>10 yr) is associated with a greater reduction in #OvarianCancer risk, and the protection is long term. https://t.co/HrrutgaYKX

— Anna Chichura, MD (@AnnaChichuraMD) July 3, 2021

Diretriz ASCO estratificada por disponibilidade de recursos | Avaliação de mulheres adultas com massas ovarianas e tratamento do câncer ovariano epitelial.

9 Ago, 2021 | 11:17h

Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline – JCO Global Oncology

Comentário: ASCO Publishes Resource-Stratified Guideline on Assessment and Treatment of Ovarian Cancer – The ASCO Post